31results about How to "Promoting blood circulation and removing stasis" patented technology

The invention discloses a traditional Chinese medicine composition for treating acute enteritis, which belongs to the technical field of medicine. It is made of the following raw materials in parts by weight: 10-50 parts of forsythia, 10-20 parts of notopterygium, 5-20 parts of angelica, 5-15 parts of scutellaria baicalensis, 5-10 parts of raw land, 5-15 parts of lily, 5-5 parts of honeysuckle 15 parts, 1-10 parts of ginseng, 5-15 parts of wolfberry, 9-15 parts of Achyranthes bidentata, 9-15 parts of Chuanxiong, 5-15 parts of Angelica dahurica, 0.2-9 parts of Ophiopogon japonicus, 5.5-15 parts of white peony root, dried ginger 6-9 parts, licorice 10-15 parts. The traditional Chinese medicine composition has a good therapeutic effect in treating or preventing acute enteritis, has low drug side effects, and has significant clinical popularization value.

The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese medicinal composition for treating solar dermatitis and a preparation method thereof. To overcome the defects of large hepatotoxicity and poor curative effect of a current chemical treatment medicament for treating solar dermatitis in the prior art, the traditional Chinese medicinal composition for treating or preventing solar dermatitis comprises the following components in parts by weight: 10-50 parts of purslane, 10-20 parts of notopterygium root, 5-20 parts of sophora flower, 5-15 parts of scutellaria baicalensis, 5-10 parts of prepared rehmannia root, 5-15 parts of lily, 5-15 parts of honeysuckle, 1-10 parts of dandelion, 5-15 parts of medlar, 9-15 parts of sculellaria barbata, 9-15 parts of ligusticum wallichii, 5-15 parts of angelica root, 0.2-9 parts of berberine, 5.5-15 parts of radix paeoniae alba, 6-9 parts of dried ginger and 10-15 parts of liquorice. The traditional Chinese medicinal composition has a good effect in preventing or treating solar dermatitis, has low toxic and side effects, and has a remarkable clinical popularization value.

The invention belongs to the technical field of medicine, and relates to a traditional Chinese medicinal composition for treating acute cholecystitis and a preparation method of the composition, aiming at the shortcomings that the chemotherapeutic drugs for acute cholecystitis have high hepatotoxicity and poor therapeutic effect. The traditional Chinese medicinal composition for treating or preventing acute cholecystiti comprises the following components in parts by weight: 10-50 parts of Andrographis paniculata, 10-20 parts of Gardenia jasminoides fruit, 5-20 parts of Sophora japonica flower, 5-15 parts of Canscora melastomacea, 5-10 parts of processed Rehmannia glutinosa, 5-15 parts of Bulbus Lilii, Flos Lonicerae 5-15 parts, 1-10 parts of Alisma orientalis, 5-15 parts of Lycium barbarum fruit, 9-15 parts of Cnidium monnieri fruit, Ligusticum chuanxiong 9-15 parts, 5-15 parts of Angelica dahurica, 0.2-9 parts of Dichondra repens, 5.5-15 parts of Paeonia lactiflora (Radix Paeoniae Alba), 6-9 parts of dried Zingiber officinale, and 10-15 parts of Radix Glycyrrhizae. The traditional Chinese medicinal composition has good effect in treating or preventing acute cholecystitis, has low adverse side effects, and has remarkable value of clinical generalization.

The invention belongs to the field of traditional Chinese medicines, relates to a traditional Chinese medicine composition and a preparation method thereof, and in particular relates to a traditional Chinese medicine composition for treating fetomaternal blood group incompatibility and a preparation method thereof. In order to overcome the existing technical problems of relatively high hepatotoxicity and poor curative effect of the current chemical medicines for treating the fetomaternal blood group incompatibility, the traditional Chinese medicine composition for treating or preventing the fetomaternal blood group incompatibility comprises the following components: 10-50 parts of epimedium, 10-20 parts of oriental wormwood, 5-20 parts of angelica sinensis, 5-15 parts of honeysuckle, 5-10 parts of the root of kudzu vine, 5-15 parts of poria cocos, 5-15 parts of lotus leaf, 1-10 parts of cassia twig, 5-15 parts of wolfberry, 9-15 parts of astragalus membranaceus, 9-15 parts of felwort, 5-15 parts of mint, 1.5-9 parts of radix ophiopogonis, 5.5-15 parts of radix paeoniae alba, 6-9 parts of spatholobus suberctu and 10-15 parts of liquorice. The traditional Chinese medicine composition has an excellent treatment effect in the aspect of treating or preventing the fetomaternal blood group incompatibility, and has low medical side effect and remarkable clinical popularization value.

The invention discloses application of a traditional Chinese medicine composition in preparing acute nephritis and relates to the technical field of traditional Chinese medicine. The traditional Chinese medicine composition is prepared from fructus forsythiae, jasmine, periostracum cicada, canscora melastomacae hand.-Mazz, paris polyphylla, lily, selfheal, rhizoma alismatis, fructus lycii, fructus cnidii, rhizomes of chuanxiong, radix angelicae, lalang grass rhizomes, radix paeoniae alba, rhizoma zingiberis, licorice roots, rhizoma cimicifugae and cassia seeds. The traditional Chinese medicine composition is a natural pure traditional Chinese medicine preparation, the adverse reactions and side effects are remarkably reduced, remarkable synergistic effects are achieved in treatment of acute nephritis, the symptoms of acute nephritis can be remarkably relieved, development of acute nephritis can also be slowed down, and the curing process of an acute nephritis patient is facilitated.

The invention discloses a traditional Chinese medicine composition for treating cervical spondylosis, and relates to the technical field of traditional Chinese medicines. Aiming at the defects that in the prior art, chemical treatment medicament for cervical spondylosis are large in hepatotoxicity and poor in curative effect, the invention provides a traditional Chinese medicine composition for treating or preventing cervical spondylosis, which is prepared from the following raw materials in parts by weight: 10-50 parts of turmeric, 10-20 parts of notopterygium roots, 5-20 parts of angelica, 5-15 parts of common yam rhizomes, 5-10 parts of radix rehmanniae, 5-15 parts of common clubmoss herbs, 5-15 parts of radix pseudostellariae, 1-10 parts of ginseng, 5-15 parts of wolfberry, 9-15 parts of achyranthes, 9-15 parts of rhizoma coptidis, 5-15 parts of radix angelicae, 1.5-9 parts of radix ophiopogonis, 5.5-15 parts of radix paeoniae alba, 6-9 parts of frankincense and 10-15 parts of licorice roots. The traditional Chinese medicine composition disclosed by the invention has a good treatment effect in treating or preventing cervical spondylosis; and the traditional Chinese medicine composition is low in side effects, and has a significant clinical promotion value.

The invention belongs to the technical field of medicine, in particular to a traditional Chinese medicine composition for treating cerebral thrombosis and a preparation method thereof. Aiming at the lack of prior art that current chemotherapeutic drugs for cerebral thrombosis have relatively high hepatotoxicity and poor curative effect, the present invention provides a traditional Chinese medicine composition for treating or preventing cerebral thrombosis, which comprises the following components: 10-50 parts of peach kernels, Notopterygium 10-20 parts, Sophora japonica 5-20 parts, Xu Changqing 5-15 parts, Rehmannia glutinosa 5-10 parts, Lily 5-15 parts, Honeysuckle 5-15 parts, Salvia miltiorrhiza 1-10 parts, Lycium barbarum 5-15 parts, Poria cocos 9-15 parts, 9-15 parts of Rhizoma Chuanxiong, 5-15 parts of Angelica dahurica, 0.2-9 parts of berberine, 5.5-15 parts of white peony, 6-9 parts of Rhodiola rosea, 10-15 parts of licorice. The traditional Chinese medicine composition has a good therapeutic effect in treating or preventing cerebral thrombosis, has low drug side effects, and has significant clinical popularization value.

The invention belongs to the field of traditional Chinese medicines, and relates to a traditional Chinese medicine composition and a preparation method thereof, in particular to a traditional Chinese medicine composition for treating acute and chronic rhinitis and a preparation method thereof. Aiming at the lack of prior art that current chemotherapeutic drugs for acute and chronic rhinitis have relatively high hepatotoxicity and poor curative effect, the present invention provides a traditional Chinese medicine composition for treating or preventing acute and chronic rhinitis, which includes the following components: Forsythia 10- 50 parts, 10-20 parts of safflower, 5-20 parts of turmeric, 5-15 parts of Xu Changqing, 5-10 parts of raw land, 5-15 parts of lily, 5-15 parts of honeysuckle, Poria? 1-10 parts, 5-15 parts of Chinese wolfberry, 9-15 parts of ephedra, 9-15 parts of Chuanxiong, 5-15 parts of Angelica dahurica, 0.2-9 parts of Radix Ophiopogon japonicus, 5.5-15 parts of Polygonum cuspidatum, 6-9 parts of Spatholobus, 10-15 parts of licorice. The traditional Chinese medicine composition has good curative effect in treating or preventing acute and chronic rhinitis, has low drug side effects, and has remarkable clinical popularization value.

The invention discloses a traditional Chinese medicine composition for treating gout, which belongs to the technical field of medicine. It is prepared from the following raw materials in parts by weight: 10-50 parts of Arthia chinensis, 10-20 parts of notopterygium, 5-20 parts of angelica, 5-15 parts of Smilax smilax, 5-10 parts of raw land, 5-15 parts of desmodium, and 5 parts of honeysuckle. -15 parts, 1-10 parts of Clematis, 5-15 parts of wolfberry, 9-15 parts of Achyranthes bidentata, 9-15 parts of Chuanxiong, 5-15 parts of Angelica dahurica, 0.2-9 parts of kudzu root, 5.5-15 parts of white peony, Ligustrum lucidum 6-9 parts, licorice 10-15 parts. The traditional Chinese medicine composition has good curative effect in the treatment or prevention of gout, has low drug side effects, and has remarkable clinical popularization value.